People respond to medications differently. Pharmacogenetic testing analyzes certain genes involved in how your body processes medications. This information can sometimes help guide medication selection or dosing decisions. We offer pharmacogenetic testing as an optional tool within a comprehensive psychiatric evaluation when clinically appropriate.
Pharmacogenetic testing is a DNA test—usually a simple cheek swab—that looks at how your body metabolizes specific medications. Results provide information about possible medication response, side-effect risk, or dosing considerations.
It does not diagnose conditions and it does not choose a medication for you. Instead, it is one piece of information used alongside clinical history, symptoms, and previous medication trials.
The process is straightforward and entirely noninvasive. Here’s what to expect:
We discuss your symptoms, treatment history, and whether testing is appropriate for your situation.
A quick, painless cheek swab is used to collect DNA for analysis.
Your sample is processed by a certified laboratory specializing in pharmacogenetic testing.
We receive a detailed report describing how your genes may affect certain medications.
We review the report together, discussing what the findings may—and may not—mean for treatment.
Test information is integrated with your clinical history to guide shared decision-making about medications.
Pharmacogenetic testing may be considered for individuals who have experienced:
For some people, pharmacogenetic testing may help:
Pharmacogenetic testing has value, but it also has limitations. It is important to understand:
We review these considerations before ordering testing so you can make an informed decision.
Testing is currently offered through secure telehealth appointments for Connecticut residents as part of psychiatric evaluation or medication management services. If you’d like to learn whether testing may be appropriate for you, contact our office.
Comprehensive assessments to clarify diagnosis, treatment needs, and recommendations for next steps.
Ongoing follow-up to monitor effectiveness, side effects, and safety of psychiatric medications.
DNA-based testing to help inform which psychiatric medications may be better tolerated or more effective.
An emotional support animal (ESA) is an animal that provides comfort, companionship, and emotional support that helps reduce the impact of mental health symptoms.
Clinical evaluations to determine eligibility for Connecticut’s medical marijuana program, with education on safe and appropriate use.
Trusted psychiatric support for public agencies and community programs.
Collaboration with schools and pediatric providers to support students through evaluation, medication management, and coordinated care.